Review



psb cb5  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Tocris psb cb5
    Figure 6. The effect of receptor blockers on the effect of 2-ADFP (EC50-EC70) combination with LPI (5 µM) on breast cancer cell line viability. The following substances and concentrations were used: CB1, SR 141716A (100 nM); CB2, SR 144528 (100 nM); GPR55, ML-193 (2 µM); GPR18, <t>PSB</t> <t>CB5</t> (3 µM); and TRPV1, capsazepine (5 µM). Incubation time 72 h, resazurin test, mean ± standard error (N = 4 experiments). (A) MCF-10A, (B) MCF-7, (C) BT-474, (D) SK-BR-3, (E) BT-20, and (F) MDA-MB- 231. *, a statistically significant difference from 2-ADFP alone, p ≤0.05, ANOVA with Holm–Sidak post-test.
    Psb Cb5, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/psb cb5/product/Tocris
    Average 93 stars, based on 15 article reviews
    psb cb5 - by Bioz Stars, 2026-05
    93/100 stars

    Images

    1) Product Images from "Two-Step Cell Death Induction by the New 2-Arachidonoyl Glycerol Analog and Its Modulation by Lysophosphatidylinositol in Human Breast Cancer Cells."

    Article Title: Two-Step Cell Death Induction by the New 2-Arachidonoyl Glycerol Analog and Its Modulation by Lysophosphatidylinositol in Human Breast Cancer Cells.

    Journal: International journal of molecular sciences

    doi: 10.3390/ijms26020820

    Figure 6. The effect of receptor blockers on the effect of 2-ADFP (EC50-EC70) combination with LPI (5 µM) on breast cancer cell line viability. The following substances and concentrations were used: CB1, SR 141716A (100 nM); CB2, SR 144528 (100 nM); GPR55, ML-193 (2 µM); GPR18, PSB CB5 (3 µM); and TRPV1, capsazepine (5 µM). Incubation time 72 h, resazurin test, mean ± standard error (N = 4 experiments). (A) MCF-10A, (B) MCF-7, (C) BT-474, (D) SK-BR-3, (E) BT-20, and (F) MDA-MB- 231. *, a statistically significant difference from 2-ADFP alone, p ≤0.05, ANOVA with Holm–Sidak post-test.
    Figure Legend Snippet: Figure 6. The effect of receptor blockers on the effect of 2-ADFP (EC50-EC70) combination with LPI (5 µM) on breast cancer cell line viability. The following substances and concentrations were used: CB1, SR 141716A (100 nM); CB2, SR 144528 (100 nM); GPR55, ML-193 (2 µM); GPR18, PSB CB5 (3 µM); and TRPV1, capsazepine (5 µM). Incubation time 72 h, resazurin test, mean ± standard error (N = 4 experiments). (A) MCF-10A, (B) MCF-7, (C) BT-474, (D) SK-BR-3, (E) BT-20, and (F) MDA-MB- 231. *, a statistically significant difference from 2-ADFP alone, p ≤0.05, ANOVA with Holm–Sidak post-test.

    Techniques Used: Incubation



    Similar Products

    psb cb5  (Tocris)
    93
    Tocris psb cb5
    Figure 6. The effect of receptor blockers on the effect of 2-ADFP (EC50-EC70) combination with LPI (5 µM) on breast cancer cell line viability. The following substances and concentrations were used: CB1, SR 141716A (100 nM); CB2, SR 144528 (100 nM); GPR55, ML-193 (2 µM); GPR18, <t>PSB</t> <t>CB5</t> (3 µM); and TRPV1, capsazepine (5 µM). Incubation time 72 h, resazurin test, mean ± standard error (N = 4 experiments). (A) MCF-10A, (B) MCF-7, (C) BT-474, (D) SK-BR-3, (E) BT-20, and (F) MDA-MB- 231. *, a statistically significant difference from 2-ADFP alone, p ≤0.05, ANOVA with Holm–Sidak post-test.
    Psb Cb5, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/psb cb5/product/Tocris
    Average 93 stars, based on 1 article reviews
    psb cb5 - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    lpi  (Tocris)
    93
    Tocris lpi
    The effect of receptor blockers on the effect of 2-ADFP (EC 50 -EC 70 ) combination with <t>LPI</t> (5 µM) on breast cancer cell line viability. The following substances and concentrations were used: CB1, SR 141716A (100 nM); CB2, SR 144528 (100 nM); GPR55, ML-193 (2 µM); <t>GPR18,</t> <t>PSB</t> CB5 (3 µM); and TRPV1, capsazepine (5 µM). Incubation time 72 h, resazurin test, mean ± standard error ( N = 4 experiments). ( A ) MCF-10A, ( B ) MCF-7, ( C ) BT-474, ( D ) SK-BR-3, ( E ) BT-20, and ( F ) MDA-MB-231. *, a statistically significant difference from 2-ADFP alone, p ≤ 0.05, ANOVA with Holm–Sidak post-test.
    Lpi, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lpi/product/Tocris
    Average 93 stars, based on 1 article reviews
    lpi - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 6. The effect of receptor blockers on the effect of 2-ADFP (EC50-EC70) combination with LPI (5 µM) on breast cancer cell line viability. The following substances and concentrations were used: CB1, SR 141716A (100 nM); CB2, SR 144528 (100 nM); GPR55, ML-193 (2 µM); GPR18, PSB CB5 (3 µM); and TRPV1, capsazepine (5 µM). Incubation time 72 h, resazurin test, mean ± standard error (N = 4 experiments). (A) MCF-10A, (B) MCF-7, (C) BT-474, (D) SK-BR-3, (E) BT-20, and (F) MDA-MB- 231. *, a statistically significant difference from 2-ADFP alone, p ≤0.05, ANOVA with Holm–Sidak post-test.

    Journal: International journal of molecular sciences

    Article Title: Two-Step Cell Death Induction by the New 2-Arachidonoyl Glycerol Analog and Its Modulation by Lysophosphatidylinositol in Human Breast Cancer Cells.

    doi: 10.3390/ijms26020820

    Figure Lengend Snippet: Figure 6. The effect of receptor blockers on the effect of 2-ADFP (EC50-EC70) combination with LPI (5 µM) on breast cancer cell line viability. The following substances and concentrations were used: CB1, SR 141716A (100 nM); CB2, SR 144528 (100 nM); GPR55, ML-193 (2 µM); GPR18, PSB CB5 (3 µM); and TRPV1, capsazepine (5 µM). Incubation time 72 h, resazurin test, mean ± standard error (N = 4 experiments). (A) MCF-10A, (B) MCF-7, (C) BT-474, (D) SK-BR-3, (E) BT-20, and (F) MDA-MB- 231. *, a statistically significant difference from 2-ADFP alone, p ≤0.05, ANOVA with Holm–Sidak post-test.

    Article Snippet: SR 144028, PSB CB5, ML-184, ML-193, capsazepine, and LPI was from Tocris Biosci- ence, Bristol, UK.

    Techniques: Incubation

    The effect of receptor blockers on the effect of 2-ADFP (EC 50 -EC 70 ) combination with LPI (5 µM) on breast cancer cell line viability. The following substances and concentrations were used: CB1, SR 141716A (100 nM); CB2, SR 144528 (100 nM); GPR55, ML-193 (2 µM); GPR18, PSB CB5 (3 µM); and TRPV1, capsazepine (5 µM). Incubation time 72 h, resazurin test, mean ± standard error ( N = 4 experiments). ( A ) MCF-10A, ( B ) MCF-7, ( C ) BT-474, ( D ) SK-BR-3, ( E ) BT-20, and ( F ) MDA-MB-231. *, a statistically significant difference from 2-ADFP alone, p ≤ 0.05, ANOVA with Holm–Sidak post-test.

    Journal: International Journal of Molecular Sciences

    Article Title: Two-Step Cell Death Induction by the New 2-Arachidonoyl Glycerol Analog and Its Modulation by Lysophosphatidylinositol in Human Breast Cancer Cells

    doi: 10.3390/ijms26020820

    Figure Lengend Snippet: The effect of receptor blockers on the effect of 2-ADFP (EC 50 -EC 70 ) combination with LPI (5 µM) on breast cancer cell line viability. The following substances and concentrations were used: CB1, SR 141716A (100 nM); CB2, SR 144528 (100 nM); GPR55, ML-193 (2 µM); GPR18, PSB CB5 (3 µM); and TRPV1, capsazepine (5 µM). Incubation time 72 h, resazurin test, mean ± standard error ( N = 4 experiments). ( A ) MCF-10A, ( B ) MCF-7, ( C ) BT-474, ( D ) SK-BR-3, ( E ) BT-20, and ( F ) MDA-MB-231. *, a statistically significant difference from 2-ADFP alone, p ≤ 0.05, ANOVA with Holm–Sidak post-test.

    Article Snippet: SR 144028, PSB CB5, ML-184, ML-193, capsazepine, and LPI was from Tocris Bioscience, Bristol, UK.

    Techniques: Incubation